<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="oil1000/PMC6609133/results/search/disease/results.xml">
  <result pre="health problem. The drugs currently used for the treatment of" exact="leishmaniasis" post="present undesirable side effects and low efficacy. In this"/>
  <result pre="1, 2 . Leishmania is the protozoan parasite responsible for" exact="leishmaniasis" post="which is manifested in visceral, mucocutaneous or cutaneous forms"/>
  <result pre="or cutaneous forms 2, 3 . Drugs currently recommended for" exact="leishmaniasis" post="treatment include compounds such as pentavalent antimonials, amphotericin B,"/>
  <result pre="(Universidade de Brasilia, Brazil) from a human case of diffuse" exact="cutaneous leishmaniasis." post="Parasites were cultured at 25 °C in Warren’s medium"/>
  <result pre="be very promising candidates for integration in nanocarriers to treat" exact="cutaneous leishmaniasis." post="A mechanism of action based on the Leishmania plasma"/>
  <result pre="2018 Jul 20 http://www.who.int/mediacentre/factsheets/fs375/en/ 3 Steverding D The history of" exact="leishmaniasis" post="Parasit Vectors 2017 10 size: 82pages 4 Davis AJ"/>
  <result pre="5 Croft SL Sundar S Fairlamb AH Drug resistance in" exact="leishmaniasis" post="Clin Microbiol Rev 2006 19 111 126 16418526 6"/>
  <result pre="Ueda-Nakamura T Dias BP Filho Nakamura CV Recent advances in" exact="leishmaniasis" post="treatment Int J Infect Dis 2011 15 e525 e532"/>
  <result pre="Copaiba Oil: an alternative to development of new drugs against" exact="leishmaniasis" post="Evid Based Complement Alternat Med 2012 2012 size: 898419pages"/>
 </snippets>
</snippetsTree>
